Last week, Danish pharmaceutical company Novo Nordisk announced its first quarter earnings beating estimates, raising its growth outlook for the rest of 2022 and expanding its buyback program, reports Reuters. Novo Nordisk’s first quarter operating profit was 19 billion Danish crowns (approximately...